| abstract |
The present invention relates to novel crystalline forms of 6-fluoro-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid [4-(4-propionyl-piperazin-1-yl)-phenyl]-amide fumarate salt. The present invention also relates to the use of said compounds for the treatment of depression, generalized anxiety, eating disorders, dementia, panic disorder, sleep disorders, gastrointestinal disorders, motor disorders, endocrine disorders, vasospasm, or sexual dysfunction, pharmaceutical compositions containing them and processes for obtaining them. |